SK279323B6 - Liečivo na aplikáciu pri odmietavých reakciách org - Google Patents

Liečivo na aplikáciu pri odmietavých reakciách org Download PDF

Info

Publication number
SK279323B6
SK279323B6 SK2582-92A SK258292A SK279323B6 SK 279323 B6 SK279323 B6 SK 279323B6 SK 258292 A SK258292 A SK 258292A SK 279323 B6 SK279323 B6 SK 279323B6
Authority
SK
Slovakia
Prior art keywords
compound
formula
manufacture
medicament
administration
Prior art date
Application number
SK2582-92A
Other languages
English (en)
Slovak (sk)
Other versions
SK258292A3 (en
Inventor
Robert R. Bartlett
Original Assignee
Hoechst Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Aktiengesellschaft filed Critical Hoechst Aktiengesellschaft
Publication of SK258292A3 publication Critical patent/SK258292A3/sk
Publication of SK279323B6 publication Critical patent/SK279323B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Meat, Egg Or Seafood Products (AREA)
SK2582-92A 1991-08-22 1992-08-21 Liečivo na aplikáciu pri odmietavých reakciách org SK279323B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4127737A DE4127737A1 (de) 1991-08-22 1991-08-22 Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen

Publications (2)

Publication Number Publication Date
SK258292A3 SK258292A3 (en) 1995-09-13
SK279323B6 true SK279323B6 (sk) 1998-10-07

Family

ID=6438804

Family Applications (1)

Application Number Title Priority Date Filing Date
SK2582-92A SK279323B6 (sk) 1991-08-22 1992-08-21 Liečivo na aplikáciu pri odmietavých reakciách org

Country Status (18)

Country Link
US (3) US5728721A (fr)
EP (1) EP0529500B1 (fr)
JP (1) JP3285226B2 (fr)
KR (1) KR100253450B1 (fr)
AT (1) ATE113835T1 (fr)
AU (1) AU654031B2 (fr)
CA (1) CA2076555C (fr)
CZ (1) CZ281353B6 (fr)
DE (2) DE4127737A1 (fr)
DK (1) DK0529500T3 (fr)
ES (1) ES2065738T3 (fr)
HU (1) HU219402B (fr)
IL (1) IL102886A (fr)
MX (1) MX9204875A (fr)
RU (1) RU2067862C1 (fr)
SK (1) SK279323B6 (fr)
TW (1) TW210284B (fr)
ZA (1) ZA926310B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133301A (en) * 1991-08-22 2000-10-17 Aventis Pharma Deutschland Gmbh Pharmaceuticals for the treatment of rejection reactions in organ transplantations
DE4127737A1 (de) 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
US5624946A (en) * 1994-07-05 1997-04-29 Williams; James Use of leflunomide to control and reverse chronic allograft rejection
CA2202904C (fr) * 1994-10-17 2006-12-19 Yukio Amano Composition preventive et remede pour les maladies allergiques de type i
DE19547648A1 (de) 1995-12-20 1997-06-26 Hoechst Ag Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
DE19610955A1 (de) * 1996-03-20 1997-09-25 Hoechst Ag Kombinationspräparat, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)- anilid und N-(4-Trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid
US6011051A (en) * 1996-07-31 2000-01-04 Hoechst Aktiengesellschaft Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
ES2150808T3 (es) * 1997-08-08 2000-12-01 Aventis Pharma Gmbh Forma cristalina de (4-trifluorometil)-anilida de acido 5-metilisoxazol-4-carboxilico.
DE19857009A1 (de) * 1998-12-10 2000-06-15 Aventis Pharma Gmbh Zubereitung mit verbesserter therapeutischer Breite, enthaltend Nukleotidsyntheseinhibitoren
DE19908527C2 (de) * 1999-02-26 2001-08-30 Aventis Pharma Gmbh Verfahren zur Kristallisation von N-(4-Trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid
FR2802101B1 (fr) 1999-12-10 2003-02-28 Aventis Pharma Sa Association de cymemazine et d'un neuroleptique atypique
DE19960443C2 (de) 1999-12-15 2002-05-08 Aventis Pharma Gmbh Verfahren zur Auffindung von Nukleotidsyntheseinhibitoren mit weniger Nebenwirkungen
CN100415227C (zh) * 2001-10-25 2008-09-03 阿特罗吉尼克斯公司 化合物在制备用于治疗移植排斥的药物中的应用
US20050158371A1 (en) * 2002-02-12 2005-07-21 Sumitomo Pharmaceuticals Co., Ltd. Novel external agent
WO2005011669A1 (fr) * 2003-08-05 2005-02-10 Dainippon Sumitomo Pharma Co., Ltd. Composition medicamenteuse pour administration percutanee
US20060024376A1 (en) * 2004-07-30 2006-02-02 The University Of Chicago Methods and compositions for reducing toxicity associated with leflunomide treatment
DE102005017592A1 (de) * 2005-04-16 2006-10-19 Lindner, Jürgen, Dr. med. Darreichungsformen und Kombinationspräparate von Pyrimidinbiosyntheseinhibitoren zur Erzielung zusätzlicher Wirkungen auf das Immunsystem
CN105272882B (zh) * 2014-07-23 2019-05-31 欣凯医药化工中间体（上海）有限公司 一种环保简便制备泰瑞米特的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2436263C2 (de) 1974-07-27 1983-02-17 Hoechst Ag, 6000 Frankfurt Thiazolidinderivate und Verfahren zu ihrer Herstellung
ES448386A1 (es) 1975-06-05 1978-04-16 Hoechst Ag Procedimiento para la preparacion de anilidas de acido 5-me-til-isoxazol-4-carboxilico.
NL186239B (nl) * 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2854439A1 (de) 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
GB8320969D0 (en) * 1983-08-03 1983-09-07 Ici Plc Transparent sheet
DE3405727A1 (de) 1984-02-17 1985-08-22 Hoechst Ag, 6230 Frankfurt Isoxazol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US5268382A (en) 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
US5100899A (en) 1989-06-06 1992-03-31 Roy Calne Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
DE4101324A1 (de) 1991-01-18 1992-07-23 Hoechst Ag Isoxazol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US6133301A (en) * 1991-08-22 2000-10-17 Aventis Pharma Deutschland Gmbh Pharmaceuticals for the treatment of rejection reactions in organ transplantations
DE4127737A1 (de) 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
EP0538783B1 (fr) 1991-10-23 1995-09-27 Hoechst Aktiengesellschaft Dérivés d'amides de l'acide n-phényl-cyano-2-hydroxy-3-crotonique et leur utilisation comme médicaments ayant des propriétés immunomodulants
US5624946A (en) 1994-07-05 1997-04-29 Williams; James Use of leflunomide to control and reverse chronic allograft rejection
US6223209B1 (en) * 1997-09-30 2001-04-24 Ncr Corporation Distributed world wide web servers

Also Published As

Publication number Publication date
US6288098B1 (en) 2001-09-11
CA2076555A1 (fr) 1993-02-23
DE59200773D1 (de) 1994-12-15
AU654031B2 (en) 1994-10-20
US20050080118A1 (en) 2005-04-14
IL102886A0 (en) 1993-01-31
DK0529500T3 (da) 1995-04-18
CZ258292A3 (en) 1993-03-17
MX9204875A (es) 1993-02-01
CA2076555C (fr) 2003-07-29
IL102886A (en) 1996-01-19
JPH05208909A (ja) 1993-08-20
ATE113835T1 (de) 1994-11-15
KR100253450B1 (ko) 2000-07-01
US7402601B2 (en) 2008-07-22
ES2065738T3 (es) 1995-02-16
DE4127737A1 (de) 1993-02-25
HU219402B (hu) 2001-04-28
TW210284B (fr) 1993-08-01
EP0529500B1 (fr) 1994-11-09
SK258292A3 (en) 1995-09-13
EP0529500A1 (fr) 1993-03-03
ZA926310B (en) 1993-04-28
AU2124792A (en) 1993-02-25
JP3285226B2 (ja) 2002-05-27
HUT64845A (en) 1994-03-28
CZ281353B6 (cs) 1996-09-11
US5728721A (en) 1998-03-17
RU2067862C1 (ru) 1996-10-20
KR930003915A (ko) 1993-03-22

Similar Documents

Publication Publication Date Title
SK279323B6 (sk) Liečivo na aplikáciu pri odmietavých reakciách org
JPH07165694A (ja) Ｎ−（４−トリフルオロメチルフェニル）−２−シアノ−３−ヒドロキシ−クロトン酸アミド
JP2650757B2 (ja) 免疫抑制剤として有用な４‐キノリンカルボン酸誘導体
JPH0662407B2 (ja) 安定化された３―オキシゲルミルプロピオン酸ポリマーを有効成分とする免疫調整剤
JP3119738B2 (ja) Ｎ−フェニル−２−シアノ−３−ヒドロキシクロトンアミド誘導体および免疫調整性を有する医薬品としてのその使用
CN101370783A (zh) 9-氧代吖啶-10-乙酸和1-烷基氨基-1-脱氧多羟基化合物的盐和混合物、包含其的药物组合物以及治疗方法
IL30782A (en) Amino guanidines
US6133301A (en) Pharmaceuticals for the treatment of rejection reactions in organ transplantations
US3966944A (en) 10 (N-methyl-4-piperidylidene)-10H[1]-benzopyrano[3,2-b]-pyridine as an analgesic, anti-inflammatory and agent against type III hypersensitivity disease
EP0617959A1 (fr) Médicament pour le traitement des maladies de la peau
US4843092A (en) Immunosuppressive agent
LT3589B (en) Using of known combination for treatment of rejection reaction by transplantation of organs
US3829581A (en) Aliphatic polycyclic amidoximes as influenza antiviral agents
KR0132568B1 (ko) 이뇨 또는 항고혈압 조성물
US10343997B1 (en) Ursolic acid derivatives
JPS61126026A (ja) イソキノリンスルホン酸アミドを有効成分とする抗癌剤
PT1562571E (pt) Combinação de derivados de diamina e agentes imunossupressores para a indução da tolerância imunológica
US4419367A (en) Stimulant
CA3157631A1 (fr) Utilisation d'un compose dans la prevention ou le traitement d'une maladie du greffon contre l'hote
JPS63225381A (ja) 肝疾患治療剤
JPS58174322A (ja) 線溶促進剤
JPS63201126A (ja) 免疫グロブリンｅに起因する疾患治療剤
WO2014156339A1 (fr) Agent gastrocinétique postprandial
JPWO2002074299A1 (ja) ＴＮＦα産生抑制剤

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20120821